Answers are grounded in this paper and cite their sources.
Substantial progress has been made toward viable, practical long-acting approaches to deliver HIV treatment and prevention through: (1) continued improvements in long-acting antiretrovirals (ARVs); (2) better innovative delivery systems; and (3) collaboration of willing partners to advance new ARVs. More progress on those 3 fronts is still needed to arrive at the goal of optimized HIV treatment and prevention for all who would benefit—and of finally controlling the HIV epidemic.
No takes yet. Share an insight, caveat, or question.
Matthew D. Barnhart (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: